Logo image of TLSA

TIZIANA LIFE SCIENCES LTD (TLSA) Stock Price, Quote, News and Overview

NASDAQ:TLSA - Nasdaq - BMG889121031 - Common Stock - Currency: USD

1.36  -0.08 (-5.56%)

After market: 1.2817 -0.08 (-5.76%)

TLSA Quote, Performance and Key Statistics

TIZIANA LIFE SCIENCES LTD

NASDAQ:TLSA (4/25/2025, 8:00:01 PM)

After market: 1.2817 -0.08 (-5.76%)

1.36

-0.08 (-5.56%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High1.91
52 Week Low0.54
Market Cap150.50M
Shares110.66M
Float71.31M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO07-14 2008-07-14


TLSA short term performance overview.The bars show the price performance of TLSA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 20 40 60

TLSA long term performance overview.The bars show the price performance of TLSA in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of TLSA is 1.36 USD. In the past month the price increased by 19.3%. In the past year, price increased by 74.34%.

TIZIANA LIFE SCIENCES LTD / TLSA Daily stock chart

TLSA Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18.39 329.14B
AMGN AMGEN INC 14.17 150.99B
GILD GILEAD SCIENCES INC 13.33 128.61B
VRTX VERTEX PHARMACEUTICALS INC 1702.9 126.96B
REGN REGENERON PHARMACEUTICALS 13.2 65.88B
ARGX ARGENX SE - ADR 330.52 37.54B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.72B
ONC BEIGENE LTD-ADR N/A 26.39B
BNTX BIONTECH SE-ADR N/A 24.52B
NTRA NATERA INC N/A 20.79B
BIIB BIOGEN INC 7.22 17.39B
SMMT SUMMIT THERAPEUTICS INC N/A 17.30B

About TLSA

Company Profile

TLSA logo image Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti IL-6R mAb (TZLS-501), a fully human mAb binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune disease and cancer, reducing circulating levels of the IL-6 cytokine.

Company Info

TIZIANA LIFE SCIENCES LTD

3rd Floor, 11-12 St. James's Square

London SW1Y 4LB GB

CEO: Kunwar Shailubhai

Employees: 9

Company Website: https://www.tizianalifesciences.com/

Investor Relations: https://ir.tizianalifesciences.com/

Phone: 442074952379

TIZIANA LIFE SCIENCES LTD / TLSA FAQ

What is the stock price of TIZIANA LIFE SCIENCES LTD today?

The current stock price of TLSA is 1.36 USD. The price decreased by -5.56% in the last trading session.


What is the ticker symbol for TIZIANA LIFE SCIENCES LTD stock?

The exchange symbol of TIZIANA LIFE SCIENCES LTD is TLSA and it is listed on the Nasdaq exchange.


On which exchange is TLSA stock listed?

TLSA stock is listed on the Nasdaq exchange.


What is TIZIANA LIFE SCIENCES LTD worth?

TIZIANA LIFE SCIENCES LTD (TLSA) has a market capitalization of 150.50M USD. This makes TLSA a Micro Cap stock.


How many employees does TIZIANA LIFE SCIENCES LTD have?

TIZIANA LIFE SCIENCES LTD (TLSA) currently has 9 employees.


What are the support and resistance levels for TIZIANA LIFE SCIENCES LTD (TLSA) stock?

TIZIANA LIFE SCIENCES LTD (TLSA) has a support level at 0.81 and a resistance level at 1.44. Check the full technical report for a detailed analysis of TLSA support and resistance levels.


Should I buy TIZIANA LIFE SCIENCES LTD (TLSA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does TIZIANA LIFE SCIENCES LTD (TLSA) stock pay dividends?

TLSA does not pay a dividend.


What is the Price/Earnings (PE) ratio of TIZIANA LIFE SCIENCES LTD (TLSA)?

TIZIANA LIFE SCIENCES LTD (TLSA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.13).


What is the Short Interest ratio of TIZIANA LIFE SCIENCES LTD (TLSA) stock?

The outstanding short interest for TIZIANA LIFE SCIENCES LTD (TLSA) is 1.06% of its float. Check the ownership tab for more information on the TLSA short interest.


TLSA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to TLSA. When comparing the yearly performance of all stocks, TLSA is one of the better performing stocks in the market, outperforming 97.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

TLSA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to TLSA. TLSA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

TLSA Financial Highlights

Over the last trailing twelve months TLSA reported a non-GAAP Earnings per Share(EPS) of -0.13. The EPS increased by 27.56% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -125.21%
ROE -740.05%
Debt/Equity 0.02
Chartmill High Growth Momentum
EPS Q2Q%46.5%
Sales Q2Q%N/A
EPS 1Y (TTM)27.56%
Revenue 1Y (TTM)N/A

TLSA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to TLSA. The Buy consensus is the average rating of analysts ratings from 7 analysts.


Ownership
Inst Owners0.88%
Ins Owners35.56%
Short Float %1.06%
Short Ratio0.93
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y13.33%
Revenue Next YearN/A